In Table 1, a percentage sign (%) is already displayed in the header (the first row of the table), and there is a redundant “%” in the newly revised data for duration of treatment. Please see the correct Table 1 here.

In the Results subsection of the Abstract, there is an error in the last sentence of the paragraph. The correct sentence is: Conversely, no statistically significant differences in HBV reactivation rates were observed between patients of different genders (P = 0.637, OR = 0.855) or across varying treatment durations (P = 0.837).

In the Impact of treatment duration on HBV reactivation subsection of the Results, there are errors in the paragraph. The correct paragraph is: Since patients with a treatment duration exceeding 30 months in each group are fewer than 20, they are excluded from the intergroup comparison of treatment durations. And there was no statistically significant difference in the incidence of HBV reactivation among lymphoma patients who underwent different treatment durations (P = 0.837). Except for patients who did not experience HBV reactivation within the 24–27 months treatment period, HBV reactivation occurred in all other stages. Among those who experienced reactivation, the highest frequency of HBV reactivation (3.41%) was observed during the 15–18 months treatment period, although there were only 3 cases. In contrast, 14 cases (2.71%) of HBV reactivation occurred during the 3–6 months treatment period (Table 1).

The publisher apologizes for the errors.

Download:

• PNG
  larger image
• TIFF
  original image

Table 1. The results of different factors affecting HBV reactivation.

https://doi.org/10.1371/journal.pone.0356789.t001